GlassScriptPhysician profile
Timothy Burton
NPI 1306292859
$2,615.11
in general payments reported to CMS, 2019-2025
8 companies · $2,069 in 2025
The $2,069 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $36.75 · 2024: $509 · 2025: $2,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $877 · Travel and Lodging: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $876.68 |
| Travel and Lodging | $238.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,769.73 | 2025 | |
| Vericel Corporation | $230.38 | 2024 | Nexobrid |
| Polynovo North America LLC | $209.67 | 2023-2025 | Novosorb Btm |
| Avita Medical Americas, LLC | $208.78 | 2025 | Permeaderm, Cohealyx, Recell |
| Aroa Biosurgery Incorporated | $76.40 | 2024-2025 | |
| Acera Surgical, INC. | $40.40 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $40.34 | 2024 | Corevalve Evolut R |
| Baxter Healthcare | $39.41 | 2024 | Artiss |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Burton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.